GSK to buy RAPT Therapeutics for $2.2 billion
20/01/2026 07:09
Jan 20 (Reuters) - GSK GSK.L said on Tuesday that it would acquire U.S.-based RAPT Therapeutics RAPT.O for $2.2 billion. (Reporting by Pushkala Aripaka in Bengaluru; Editing by Subhranshu Sahu) ((Pushkala.A@thomsonreuters.com; X and LinkedIn: @pullthekart;))